Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells

There is currently intensive research on the design of novel human immunodeficiency virus type 1 (HIV-1) vaccine immunogens that can elicit potent neutralizing antibodies. A prerequisite for comparing and optimizing these strategies is the ability to precisely measure neutralizing antibody responses...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mascola, John R., Louder, Mark K., Winter, Christine, Prabhakara, Ranjani, De Rosa, Stephen C., Douek, Daniel C., Hill, Brenna J., Gabuzda, Dana, Roederer, Mario
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2002
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC136170/
https://ncbi.nlm.nih.gov/pubmed/11967298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.10.4810-4821.2002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak